A 16-wk, Uni-center, Randomized, Double-blind, Parallel, Phase 3b Trial to Evaluate Efficacy of Saxagliptin + Dapagliflozin vs.Dapagliflozin With Regard to EGP in T2DM With Insufficient Glycemic Control on Metformin+/-Sulfonylurea Therapy
Phase of Trial: Phase III
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Dapagliflozin/saxagliptin (Primary) ; Dapagliflozin; Saxagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 17 Jan 2018 Planned End Date changed from 1 Jan 2018 to 1 Jun 2018.
- 17 Jan 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jun 2018.
- 20 Jun 2016 Status changed from not yet recruiting to recruiting.